Digest Network Come funziona
Network
/
Società
As
Non verificato

Astria Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

59 comunicati stampa

Guarda tutti i comunicati
12/11/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Mercato azionario
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
06/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
31/10/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/10/2025
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Mercato del lavoro
Telefonia e Varie
Mercato azionario
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Eventi
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/10/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
03/10/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Finanza
Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2025
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Industria
Astria Therapeutics sta arruolando pazienti affetti da angioedema ereditario (HAE) nell’Unione Europea per il trial di fase 3 ALPHA-ORBIT
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Industria
Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial
Fonte
Astria Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0